Measles vaccines: WHO position paper – April 2017

Overview

This position paper incorporates the most recent developments in the field of measles and includes removal of introduction criteria for the routine second dose of measles-containing vaccine (MCV2), guidance on when to vaccinate infants from 6 months of age, and guidance on re-vaccination of HIV-infected children receiving highly active anti-retroviral therapy (HAART). It replaces the 2009 WHO position paper on measles vaccines.